BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29109152)

  • 1. Prodomain-growth factor swapping in the structure of pro-TGF-β1.
    Zhao B; Xu S; Dong X; Lu C; Springer TA
    J Biol Chem; 2018 Feb; 293(5):1579-1589. PubMed ID: 29109152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent TGF-β structure and activation.
    Shi M; Zhu J; Wang R; Chen X; Mi L; Walz T; Springer TA
    Nature; 2011 Jun; 474(7351):343-9. PubMed ID: 21677751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of the Prodomain α1-Helix Correlates with Latency in the Transforming Growth Factor-β Family.
    Le VQ; Iacob RE; Zhao B; Su Y; Tian Y; Toohey C; Engen JR; Springer TA
    J Mol Biol; 2022 Mar; 434(5):167439. PubMed ID: 34990654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and activation of pro-activin A.
    Wang X; Fischer G; Hyvönen M
    Nat Commun; 2016 Jul; 7():12052. PubMed ID: 27373274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the TGF-beta latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-betas.
    Kusakabe M; Cheong PL; Nikfar R; McLennan IS; Koishi K
    J Cell Biochem; 2008 Jan; 103(1):311-20. PubMed ID: 17516499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation.
    Le VQ; Iacob RE; Tian Y; McConaughy W; Jackson J; Su Y; Zhao B; Engen JR; Pirruccello-Straub M; Springer TA
    EMBO J; 2018 Feb; 37(3):384-397. PubMed ID: 29343545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex.
    Walton KL; Makanji Y; Chen J; Wilce MC; Chan KL; Robertson DM; Harrison CA
    J Biol Chem; 2010 May; 285(22):17029-37. PubMed ID: 20308061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β.
    Alcaraz LB; Exposito JY; Chuvin N; Pommier RM; Cluzel C; Martel S; Sentis S; Bartholin L; Lethias C; Valcourt U
    J Cell Biol; 2014 May; 205(3):409-28. PubMed ID: 24821840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
    Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. You're going to need a bigger (glass bottom) boat.
    Peterson AJ; O'Connor MB
    Sci Signal; 2012 Apr; 5(218):pe14. PubMed ID: 22472647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences.
    Anderson EN; Wharton KA
    J Biol Chem; 2017 Nov; 292(47):19160-19178. PubMed ID: 28924042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteins.
    Warren J; Im M; Ballesteros A; Ha C; Moore T; Lambert F; Lucas S; Hinz B; Dveksler G
    Mol Hum Reprod; 2018 Dec; 24(12):602-612. PubMed ID: 30371828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin inhibits activation of latent transforming growth factor-β1.
    Lee MJ
    Pharmacology; 2013; 92(5-6):238-44. PubMed ID: 24247664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of bone morphogenetic protein 9 procomplex.
    Mi LZ; Brown CT; Gao Y; Tian Y; Le VQ; Walz T; Springer TA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3710-5. PubMed ID: 25751889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Force interacts with macromolecular structure in activation of TGF-β.
    Dong X; Zhao B; Iacob RE; Zhu J; Koksal AC; Lu C; Engen JR; Springer TA
    Nature; 2017 Feb; 542(7639):55-59. PubMed ID: 28117447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme.
    Dubois CM; Blanchette F; Laprise MH; Leduc R; Grondin F; Seidah NG
    Am J Pathol; 2001 Jan; 158(1):305-16. PubMed ID: 11141505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Basis of the Ligand Binding Specificity of αvβ8 Integrin.
    Ozawa A; Sato Y; Imabayashi T; Uemura T; Takagi J; Sekiguchi K
    J Biol Chem; 2016 May; 291(22):11551-65. PubMed ID: 27033701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of bone morphogenetic protein-4 activity by sequence elements within the prodomain.
    Sopory S; Nelsen SM; Degnin C; Wong C; Christian JL
    J Biol Chem; 2006 Nov; 281(45):34021-31. PubMed ID: 16966322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of a C-terminal extension sequence to transforming growth factor-beta 1 interferes with biosynthetic processing and abolishes biological activity.
    Wakefield LM; Kondaiah P; Hollands RS; Winokur TS; Sporn MB
    Growth Factors; 1991; 5(3):243-53. PubMed ID: 1663772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin Biosynthesis and Activity Are Limited by a Prodomain-Derived Peptide.
    Walton KL; Kelly EK; Chan KL; Harrison CA; Robertson DM
    Endocrinology; 2015 Aug; 156(8):3047-57. PubMed ID: 25961838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.